NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,339 | -68.9% | 11,864 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $26,813 | -29.4% | 11,864 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $38,000 | -15.6% | 11,864 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $45,000 | -29.7% | 11,864 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $64,000 | -53.6% | 11,864 | +15.7% | 0.00% | -60.0% |
| Q4 2021 | $138,000 | -25.0% | 10,250 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $184,000 | +4.5% | 10,250 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $176,000 | -14.1% | 10,250 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $205,000 | +17.8% | 10,250 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $174,000 | +2.4% | 10,250 | 0.0% | 0.01% | +14.3% |
| Q3 2020 | $170,000 | -28.3% | 10,250 | 0.0% | 0.01% | -46.2% |
| Q2 2020 | $237,000 | +23.4% | 10,250 | -4.5% | 0.01% | -7.1% |
| Q1 2020 | $192,000 | -23.2% | 10,730 | -7.4% | 0.01% | 0.0% |
| Q4 2019 | $250,000 | -70.0% | 11,587 | -17.0% | 0.01% | -73.6% |
| Q4 2017 | $833,000 | +148.7% | 13,952 | 0.0% | 0.05% | +130.4% |
| Q3 2017 | $335,000 | +12.0% | 13,952 | -8.7% | 0.02% | +9.5% |
| Q2 2017 | $299,000 | -6.3% | 15,283 | +12.5% | 0.02% | -4.5% |
| Q1 2017 | $319,000 | +132.8% | 13,587 | +21.4% | 0.02% | +120.0% |
| Q4 2016 | $137,000 | -28.6% | 11,195 | 0.0% | 0.01% | -37.5% |
| Q3 2016 | $192,000 | +20.8% | 11,195 | 0.0% | 0.02% | +14.3% |
| Q2 2016 | $159,000 | +3.2% | 11,195 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $154,000 | -9.9% | 11,195 | +10.2% | 0.01% | -17.6% |
| Q4 2015 | $171,000 | +54.1% | 10,160 | 0.0% | 0.02% | +41.7% |
| Q3 2015 | $111,000 | – | 10,160 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |